Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-011390
Filing Date
2020-11-27
Accepted
2020-11-27 18:07:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27624
2 filename2.txt TEXT-EXTRACT 1418
  Complete submission text file 0000000000-20-011390.txt   40121
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filed for) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations